| 000 | 01560 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516120951.0 | ||
| 264 | 0 | _c20130610 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.01473-12 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Ping | |
| 245 | 0 | 0 |
_aPopulation pharmacokinetic-pharmacodynamic analysis of anidulafungin in adult patients with fungal infections. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cJan 2013 |
||
| 300 |
_a466-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnidulafungin |
| 650 | 0 | 4 |
_aAntifungal Agents _xblood |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aCandida _xdrug effects |
| 650 | 0 | 4 |
_aCandidemia _xblood |
| 650 | 0 | 4 |
_aCandidiasis, Invasive _xblood |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEchinocandins _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 57 _gno. 1 _gp. 466-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01473-12 _zAvailable from publisher's website |
| 999 |
_c22242191 _d22242191 |
||